Quote of the Day

“CMS has a bias toward anything that can reasonably reduce costs for beneficiaries. They will tend to encourage market-tested policies that can keep costs low — because remember, when costs are low, they are low not only for consumers; they’re low for the federal government….CMS does not want to increase the cost structure for the plans.” — Dan Mendelson, a former White House Office of Management and Budget official who is now CEO of Avalere Health LLC, told AIS’s Drug Benefit News. Click here to read the DRUG BENEFIT NEWS article in which this quote appeared. (Free for DBN subscribers; $17 for non-subscribers).